Cleared Special

K181954 - autoLog IQ Autotransfusion System

K181954 is an FDA 510(k) clearance for autoLog IQ Autotransfusion System, manufactured by Medtronic Perfusion Systems. The device is a Class 2 Cardiovascular device with product code CAC cleared through the Special 510(k) pathway after a 30-day FDA review.

K181954 · Medtronic Perfusion Systems · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2018
Decision
30d
Days
Class 2
Risk

K181954 is an FDA 510(k) clearance for the autoLog IQ Autotransfusion System. Classified as Apparatus, Autotransfusion (product code CAC), Class II - Special Controls.

Submitted by Medtronic Perfusion Systems (Minneapolis, US). The FDA issued a Cleared decision on August 22, 2018 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 868.5830 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Medtronic Perfusion Systems devices

FDA 510(k) Submission Details - K181954

510(k) Number K181954 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2018
Decision Date August 22, 2018
Days to Decision 30 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
95d faster than avg
Panel avg: 125d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

CAC Device Classification - Class 2, Special Controls

Product Code CAC Apparatus, Autotransfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5830
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - CAC Apparatus, Autotransfusion

All 165
Devices cleared under the same product code (CAC) and FDA review panel - the closest regulatory comparables to K181954.
ProCell Surgical Sponge-Blood Recovery Unit
K193361 · Procell Surgical, Inc. · Jun 2020
CATSmart
K192368 · Fresenius Kabi AG · Sep 2019
CATSmart
K180831 · Fresenius Kabi AG · Dec 2018
Haemonetics Cell Saver Elite/Elite+ Autotransfusion System
K162423 · Haemonetics Corporation · Jan 2017
CATSmart
K160735 · Fresenius Kabi AG · Sep 2016
Haemonetics Cell Saver Elite Autotransfusion System
K160197 · Haemonetics Corporation · May 2016